Organization Statistics
Avg Compliance Rate
48.60%
Compliant Trials
486
Incompliant submissions
514
Total Organizations
46697
Total trials
1000
Filter Organizations
Compare Organization Compliance Rates
Showing 225 of 46697 entries
View as:
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 3
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 2
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 2
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 5
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 2
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 15
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 2
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 2
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 2
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 3
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 5
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 32
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 61
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
| Sponsor | Funding Source | Total Trials | Reporting Rate | Compliant Trials | Late Submissions | Compliance Rate | Wilson LCB Score | Email Domain | Created Date |
|---|---|---|---|---|---|---|---|---|---|
| A Bapsi Chakravarthy, MD | - | 1 | 0.0% | 0 | 0 | 0.0% | - | A Bapsi Chakravarthy, MD.temp.org | 2025-07-14 |
| A Thousand Colibris, S.L | - | 1 | 0.0% | 0 | 0 | 0.0% | - | A Thousand Colibris, S.L.temp.org | 2025-07-14 |
| A&G Pharmaceutical Inc. | - | 1 | 0.0% | 0 | 0 | 0.0% | - | A&G Pharmaceutical Inc..temp.org | 2025-07-14 |
| A-Mansia Biotech S.A. | - | 3 | 0.0% | 0 | 0 | 0.0% | - | A-Mansia Biotech S.A..temp.org | 2025-07-14 |
| A-Rhythmik GmbH | - | 1 | 0.0% | 0 | 0 | 0.0% | - | A-Rhythmik GmbH.temp.org | 2025-07-14 |
| A-Spine Asia Co., Ltd. | - | 1 | 0.0% | 0 | 0 | 0.0% | - | A-Spine Asia Co., Ltd..temp.org | 2025-07-14 |
| A. D. Struthers | - | 1 | 0.0% | 0 | 0 | 0.0% | - | A. D. Struthers.temp.org | 2025-07-14 |
| A. Eden Evins | - | 2 | 0.0% | 0 | 0 | 0.0% | - | A. Eden Evins.temp.org | 2025-07-14 |
| A. Janet Tomiyama | - | 2 | 0.0% | 0 | 0 | 0.0% | - | A. Janet Tomiyama.temp.org | 2025-07-14 |
| A. M. Zeiher | - | 1 | 0.0% | 0 | 0 | 0.0% | - | A. M. Zeiher.temp.org | 2025-07-14 |
| A. Manzoni Hospital | - | 5 | 0.0% | 0 | 0 | 0.0% | - | A. Manzoni Hospital.temp.org | 2025-07-14 |
| A. Menarini Industrie Farmaceutiche Riunite S.r.l. | - | 2 | 0.0% | 0 | 0 | 0.0% | - | A. Menarini Industrie Farmaceutiche Riunite S.r.l..temp.org | 2025-07-14 |
| A. Vogel AG | - | 15 | 0.0% | 0 | 0 | 0.0% | - | A. Vogel AG.temp.org | 2025-07-14 |
| A.A. Partners, LLC | - | 2 | 0.0% | 0 | 0 | 0.0% | - | A.A. Partners, LLC.temp.org | 2025-07-14 |
| A.C. Abrahams | - | 1 | 0.0% | 0 | 0 | 0.0% | - | A.C. Abrahams.temp.org | 2025-07-14 |
| A.G. Huppelschoten | - | 2 | 0.0% | 0 | 0 | 0.0% | - | A.G. Huppelschoten.temp.org | 2025-07-14 |
| A.H. Tavenier | - | 1 | 0.0% | 0 | 0 | 0.0% | - | A.H. Tavenier.temp.org | 2025-07-14 |
| A.J.C. Slooter | - | 1 | 0.0% | 0 | 0 | 0.0% | - | A.J.C. Slooter.temp.org | 2025-07-14 |
| A.J.M. van den Eertwegh | - | 2 | 0.0% | 0 | 0 | 0.0% | - | A.J.M. van den Eertwegh.temp.org | 2025-07-14 |
| A.M.I. Agency for Medical Innovations GmbH | - | 3 | 0.0% | 0 | 0 | 0.0% | - | A.M.I. Agency for Medical Innovations GmbH.temp.org | 2025-07-14 |
| A.Menarini Asia-Pacific Holdings Pte Ltd | - | 5 | 0.0% | 0 | 0 | 0.0% | - | A.Menarini Asia-Pacific Holdings Pte Ltd.temp.org | 2025-07-14 |
| A.O. Ospedale Papa Giovanni XXIII | - | 32 | 0.0% | 0 | 0 | 0.0% | - | A.O. Ospedale Papa Giovanni XXIII.temp.org | 2025-07-14 |
| A.O.U. Città della Salute e della Scienza | - | 61 | 0.0% | 0 | 0 | 0.0% | - | A.O.U. Città della Salute e della Scienza.temp.org | 2025-07-14 |
| A.O.U. San Giovanni Battista di Torino, Italy | - | 1 | 0.0% | 0 | 0 | 0.0% | - | A.O.U. San Giovanni Battista di Torino, Italy.temp.org | 2025-07-14 |
| A.P.J. Vlaar | - | 1 | 0.0% | 0 | 0 | 0.0% | - | A.P.J. Vlaar.temp.org | 2025-07-14 |